| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 7,890,361 | 4,898,010 |
| Effect of foreign exchange rate on changes on cash | -17,113 | -7,496 |
| Net increase in cash | 1,516,568 | 608,790 |
| Cash and cash equivalents at beginning of period | 2,241,026 | - |
| Cash and cash equivalents at end of period | 3,757,594 | - |
Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. (ENVB)